Offerings Archives - Page 127 of 166

2 minute read

Reported Early Thursday, Tenaya Therapeutics Announces Pricing Of Public Offering Of 22,613,307 Shares Of Common Stock At A Price Of $2.60/Share

November 17, 2:25 AM

Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today

TNYA

3 minute read

Reported Early Thursday, Brookdale Announces Pricing Of 2.5M Of Its 7% Tangible Equity Units At A Price Of $50/Unit Public Offering

By Benzinga Newsdesk

November 17, 2:23 AM

Brookdale Senior Living Inc. (NYSE:BKD) ("Brookdale" or the "Company") announced today that it has priced its previously announced public offering of 2.5 million of its 7.00% tangible equity

BKD

2 minute read

Reported Early Thursday, Biodesix Announces Pricing Of $35.1 Million Upsized Public Offering Of 30.5M Shares Of Common Stock At A Price Of $1.15/Share

By Benzinga Newsdesk

November 17, 2:20 AM

Biodesix, Inc. (NASDAQ:BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced the pricing of an underwritten public offering of 30,500,000 shares of its common stock

BDSX

2 minute read

Reported Late Wednesday, Ormat Announces Pricing Of Upsized Public Offering Of 3.75M Shares Of Common Stock On Behalf Of Stockholder ORIX Corporation At A Price Of $90/Share

By Benzinga Newsdesk

November 17, 2:12 AM

Ormat Technologies, Inc. (NYSE:ORA) ("Ormat"), a leading geothermal, energy storage, solar PV and recovered energy power company, announced today the pricing of an upsized underwritten secondary offering of

ORA

2 minute read

Reported Late Wednesday, DZS Announces Pricing Of ~$28.8M Public Offering Of ~3,377,315 Shares At A Price Of $11.50/Share; 2,507,750 Shares Are Being Offered By The Company And 869,565 Shares Are Being Offered By The Selling Stockholder

By Benzinga Newsdesk

November 17, 2:07 AM

DZS Inc. (NASDAQ:DZSI) (the "Company" or "DZS"), a global leader in access and optical edge infrastructure and cloud software solutions, today announced that it has priced an underwritten registered

DZSI

2 minute read

Reported Late Wednesday, Privia Health Announces Pricing Of Secondary Offering Of 5M Shares At A Price Of $23.50/Share

By Benzinga Newsdesk

November 17, 2:04 AM

Privia Health Group, Inc. (NASDAQ:PRVA, or ", Privia Health", or the ", Company", )))) announced the pricing of its previously announced underwritten public offering of 5,000,000 shares of common stock by

PRVA

3 minute read

Reported Late Wednesday, Bionomics Announces Pricing Of Underwritten Offering Of 641,026 American Depositary Shares In The U.S. At A Price Of $7.80/ADS

By Benzinga Newsdesk

November 17, 1:57 AM

Bionomics Limited ((ASX: BNO, NASDAQ:BNOX), ("Bionomics" or the "Company"), a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the

BNOX

2 minute read

DZS Announces Launch of Public Offering Of ~2.507M Shares Of Common Stock

By Benzinga Newsdesk

November 16, 5:01 PM

DZS Inc. (NASDAQ:DZSI) (the “Company” or “DZS”), a global leader in access and optical edge infrastructure and cloud software solutions, today announced the launch of an underwritten registered

DZSI

3 minute read

SenesTech, Inc. Announces Pricing Of $5M Public Offering Of Up To 1,428,572 Shares At A Price Of $3.50 Per Share

By Benzinga Newsdesk

November 16, 2:17 PM

SenesTech, Inc. (NASDAQ:SNES, ", , SenesTech", , or the ", , Company", , )))) (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and

SNES